Feng Ting, Wei Yumeng, Lee Robert J, Zhao Ling
Department of Pharmaceutics, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, People's Republic of China.
Division of Pharmaceutics, College of Pharmacy, The Ohio State University, Columbus, OH, USA.
Int J Nanomedicine. 2017 Aug 21;12:6027-6044. doi: 10.2147/IJN.S132434. eCollection 2017.
Curcumin (CUR) is a yellow polyphenolic compound derived from the plant turmeric. It is widely used to treat many types of diseases, including cancers such as those of lung, cervices, prostate, breast, bone and liver. However, its effectiveness has been limited due to poor aqueous solubility, low bioavailability and rapid metabolism and systemic elimination. To solve these problems, researchers have tried to explore novel drug delivery systems such as liposomes, solid dispersion, microemulsion, micelles, nanogels and dendrimers. Among these, liposomes have been the most extensively studied. Liposomal CUR formulation has greater growth inhibitory and pro-apoptotic effects on cancer cells. This review mainly focuses on the preparation of liposomes containing CUR and its use in cancer therapy.
姜黄素(CUR)是一种从植物姜黄中提取的黄色多酚类化合物。它被广泛用于治疗多种疾病,包括肺癌、宫颈癌、前列腺癌、乳腺癌、骨癌和肝癌等癌症。然而,由于其水溶性差、生物利用度低、代谢快以及全身清除率高,其有效性受到了限制。为了解决这些问题,研究人员试图探索新型药物递送系统,如脂质体、固体分散体、微乳、胶束、纳米凝胶和树枝状大分子。其中,脂质体的研究最为广泛。脂质体姜黄素制剂对癌细胞具有更强的生长抑制和促凋亡作用。本综述主要关注含姜黄素脂质体的制备及其在癌症治疗中的应用。